Transmyocardial Revascularization (TMR) utilizing a Holmium:YAG laser was approved by the FDA for the treatment of severe angina in patients whose chronic angina symptoms are not relived by medication and have an area of the heart that cannot be treated by percutaneous intervention or bypass surgery.

3 out of 4 patients who received TMR in studies, have shown a significant reduction in their angina pain¹

These important patient benefits have been shown to endure beyond five years, and may help patients live longer²

TMR is reimbursed by Medicare and Blue Cross/Blue Shield when performed as a stand alone procedure and when performed as a compliment to bypass surgery.